Loading clinical trials...
Loading clinical trials...
The primary aim of the study is to identify a predictive molecular signature for response to chemotherapy, according to WHO criteria, in patients with non-small cell lung cancer by studying the transc...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
European Lung Cancer Working Party
NCT06772623 · Non Small Cell Lung Carcinoma
NCT07369596 · Non Small Cell Lung Carcinoma NSCLC
NCT07563205 · Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, and more
NCT01941316 · Small Cell Lung Carcinoma, Non Small Cell Lung Carcinoma, and more
NCT00759382 · Non Small Cell Lung Carcinoma
Department of Pneumology Clinique Saint-Luc
Bouge
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet
Brussels
Service de Pneumologie Hôpital Erasme
Brussels
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions